The effect of bovine IFN-α on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 10, 2004, Pages 701-706

  Guo, Hui Chen ^a   Liu, Zai Xin ^a   Sun, Shi Qi ^a   Leng, Qing Wen ^b   Li, Dong ^a   Liu, Xiang Tao ^a   Xie, Qing Ge ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

DNA vaccine; Foot and mouth disease virus (FMDV); Gene vaccination; IFN

Indexed keywords

ALPHA INTERFERON; DNA VACCINE; FOOT AND MOUTH DISEASE VACCINE;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; FOOT DISEASE; GENETIC CODE; GUINEA PIG; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; MOUTH DISEASE; NONHUMAN; SEROTYPE; T LYMPHOCYTE; VACCINATION;

BOVINAE; CAVIA; CAVIA PORCELLUS; FOOT-AND-MOUTH DISEASE VIRUS; SUS SCROFA;

EID: 10044272257     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.10.701     Document Type: Article

References (26)

1. Carroll AR, Rowlands DJ, Clarke BE. The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res, 1984, 12: 2461-2472
2. Fross S, Strebel K, Beck E, Schaller H. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res, 1984, 12: 6587-6601
3. Gibbens JC, Sharpe CE, Wilesmith JW, Mansley LM, Michalopoulou E, Ryan JB, Hudson M. Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: The first five months. Vet Rec, 2001, 149: 729-743
4. Knowles NJ, Samuel AR, Davies PR, Kitching RP. Donaldson AI. Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet Rec, 2001, 148: 258-259
5. Yang PC, Chu RM, Chung WB, Sung HT. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet Rec, 1999, 145: 731-734
6. Baxt B, Vakharia V, Moore DM, Franke AJ, Morgan DO. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol, 1989, 63: 2143-2151
7. King AM, Underwood BO, McCahon D, Newman JWI, Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature, 1981, 293: 479-480
8. Bachrach HL. Foot-and-mouth disease. Annu Rev Microbiol, 1968, 22: 201-244
9. Cedillo-Barron L, Foster-Cuevas M, Belsham G J, Lefevre F, Parkhouse E. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol, 2001, 82: 1713-1724
10. Wong HT, Cheng SC, Chan EW, Sheng ZT, Yang WY, Zheng ZX, Xie Y. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology, 2000, 278: 27-35
11. Beard C, Ward G, Rieder E. Chinsangaram J. Grubman MJ. Mason PW. Development of DNA vaccines for foot-and-mouth disease evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J Biotechnol, 1999, 73: 243-249
12. Yang JS, Kim JJ, Hwang D, Choo AY, Dang K, Maguire H, Kudchodkar S et al. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY 1999). J Infect Dis, 2001, 184(7): 809-816
13. Nobiron I, Thompson I, Brownlie J, Collins ME. Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice. Vaccine, 2001, 19(30): 4226-4235
14. Tighe H, Corr M, Roman M, Raz E. Gene vaccination: Plasmid DNA is more than just a blueprint. Immunol Today, 1998; 19: 89-97
15. Sin JI, Weiner DB. Improving DNA vaccines targeting viral infection. Intervirology, 2000, 43: 233-246
16. Ryan MD, Belsham GJ, King AM. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology, 1989, 173: 35-45
17. Belsham GJ, Brangwyn JK, Ryan MD, Abrams CC, King AM. Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: Influence of the L protease. Virology, 1990, 176: 524-530
18. Abrams CC, King AM, Belsham GJ. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J Gen Viral, 1995, 76: 3089-3098
19. Foster M, Cook A, Cedillo L, Parkhouse RM. Serological and cellular immune response to non-structural proteins in animals infected with FMDV. Vet Q, 1998, 20(Suppl2): s28-s30
20. Collen T, Baron J, Childerstone A, Corteyn A, Doel TR, Flint M, Garcia-Valcarcel M et al. Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: The polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res, 1998, 56: 125-133
21. Goodbourn S, Didcock L, Randall RE. Interferons: Cell signaling, immune modulation, antiviral response and virus countermeasures. J Gen Virol, 2000, 81: 2341-2364
22. Zhou A, Paranjape JM, Der SD, Williams BR, Silverman RH. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology, 1999, 258: 435-440
23. Ahl R, Rump A. Assay of bovine interferons in cultures of the porcine cell line IB-RS-2. Infect Immun, 1976, 14: 603-606
24. Chinsangaram J, Koster M, Grubman MJ. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol, 2001, 75(12): 5498-5503
25. Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol, 1999, 73: 9891-9898
26. Sellers RF. Multiplication, interferon production and sensitivity of virulent and attenuated strains of the virus of foot-and-mouth disease. Nature, 1963, 198: 1228-1229